Search Results - "Abiteboul, Kathy"

  • Showing 1 - 17 results of 17
Refine Results
  1. 1
  2. 2

    Safety of STG320 Sublingual Tablets of House Dust Mite Allergen Extracts in Subjects with HDM-Associated Allergic Rhinitis: Results of a Pooled Analysis by Demoly, Pascal M., Prof, Bergmann, Karl-Christian, Prof, Khairallah, Sandrine, Mrs, Abiteboul, Kathy, Dr, Zeldin, Robert K., Dr

    Published in Journal of allergy and clinical immunology (01-02-2016)
    “…Rationale Safety of house dust mite (HDM) sublingual tablets (STG320) for the treatment of HDM-associated allergic rhinitis (AR) with or without intermittent…”
    Get full text
    Journal Article
  3. 3

    Efficacy of 300IR 5-Grass Pollen Sublingual Tablet in the Treatment of Rhinitis Symptoms in Polysensitized Subjects with Grass Pollen-Induced Allergic Rhinoconjunctivitis by Zeldin, Robert K., MD, Amistani, Yann, MSc, Cognet-Sicé, Josiane, PharmD, Abiteboul, Kathy, PharmD

    Published in Journal of allergy and clinical immunology (01-02-2016)
    “…The means of each of the individual symptom scores in the 300IR group (n=427) were significantly lower than in the placebo group (n=464) with relative…”
    Get full text
    Journal Article
  4. 4

    Long-Term Treatment with 300IR 5-Grass Pollen Sublingual Tablet in Grass Pollen Allergic Subjects: Safety Outcome Year after Year by Golden, David B.K., MD, FAAAAI, Fahrenholz, John M., MD, FAAAAI, Renahan, Kevin E., MSci, Khairallah, Sandrine, MSci, Abiteboul, Kathy, PharmD

    Published in Journal of allergy and clinical immunology (01-02-2017)
    “…Rationale To investigate the safety outcomes in subjects with grass pollen-induced allergic rhinoconjunctivitis (ARC) receiving 300IR 5-grass pollen sublingual…”
    Get full text
    Journal Article
  5. 5
  6. 6
  7. 7

    Reply by Bergmann, Karl-Christian, Demoly, Pascal, Abiteboul, Kathy, Zeldin, Robert K

    Published in Journal of allergy and clinical immunology (01-01-2015)
    “…[...]the author of the correspondence makes reference to a value of 0.55 as the minimal clinically important difference…”
    Get full text
    Journal Article
  8. 8
  9. 9
  10. 10

    Immunological Markers In House Dust Mite Allergic Subjects Treated With 300IR House Dust Mite Sublingual Tablets: Results From Two Phase III Trials by Demoly, Pascal M., Bergmann, Karl-Christian, Okamoto, Yoshitaka, Abiteboul, Kathy, Relwani, Kanchan

    Published in Journal of allergy and clinical immunology (01-02-2018)
    “…Rationale Efficacy and safety of house dust mite (HDM) sublingual tablets have been studied in subjects with HDM-associated allergic rhinitis (HDM-AR). In both…”
    Get full text
    Journal Article
  11. 11
  12. 12
  13. 13

    Safety of 300IR 5-Grass Tablet in Children with Grass Pollen-Induced Allergic Rhinoconjunctivitis: Results of an Observational, Post-Marketing Safety Study by Gertslauer, Michael, Szepfalusi, Zsolt, Golden, David B.K., Viatte, Agnès, Melac, Michel, Abiteboul, Kathy, Jacques de Blic

    Published in Journal of allergy and clinical immunology (01-02-2018)
    “…Rationale We report safety data of 300IR 5-grass pollen tablet* from a post-marketing study conducted in grass pollen-allergic children in Europe. Methods This…”
    Get full text
    Journal Article
  14. 14
  15. 15
  16. 16
  17. 17